| 0.0905 0 (0%) | 09-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.46 | 1-year : | 0.74 |
| Resists | First : | 0.39 | Second : | 0.63 |
| Pivot price | 0.01  |
|||
| Supports | First : | 0 | Second : | 0 |
| MAs | MA(5) : | 0 | MA(20) : | 0.04 |
| MA(100) : | 0.15 |
MA(250) : | 0.99 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 0 |
D(3) : | 0 |
| RSI | RSI(14): 37.2 | |||
| 52-week | High : | 2.89 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SNYR ] has closed above bottom band by 31.3%. Bollinger Bands are 0.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0 - 0 | 0 - 0 |
| Low: | 0 - 0 | 0 - 0 |
| Close: | 0 - 0 | 0 - 0 |
Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom. The company's brand portfolio features FOCUSfactor, specializing in nutritional supplements aimed at enhancing brain function. It also offers the Flat Tummy line, which includes a range of wellness and fashion items such as specialty teas, meal replacement shakes, lollipops, dietary aids, apparel, and exercise accessories. Furthermore, under the Hand MD brand, Synergy CHC Corp. provides anti-aging skincare products, encompassing serums and creams designed for exfoliation, skin repair, and rehydration, as well as hand hygiene products like soaps and sanitizers. These goods are made available to consumers through conventional retail partners and significant television advertising campaigns. The company's skincare range, in particular, is also sold directly via online platforms. Founded in 2010, the firm was originally named Synergy Strips Corp. and rebranded to Synergy CHC Corp. in August 2015. Its primary business operations are based in Westbrook, Maine.
Fri, 06 Nov 2026
Synergy CHC Corp. Common Stock (NASDAQ: SNYR) Stock Price, News & Analysis - kalkine.ca
Wed, 16 Sep 2026
Synergy CHC Received Notice of Delisting - TradingView
Wed, 16 Sep 2026
Synergy CHC Corp. (SNYR) surges as traders appear to chase a volatile bankruptcy rebound - Quiver Quantitative
Fri, 21 Aug 2026
Synergy CHC Received Notice of Noncompliance - TradingView
Fri, 21 Aug 2026
Synergy CHC Corp. Receives Nasdaq Non-Compliance Notice Over Delayed Q2 2026 Form 10-Q Filing - Quiver Quantitative
Fri, 21 Aug 2026
Synergy CHC Corp. Receives Nasdaq Non-Compliance Notice Over Delayed Q2 2026 Form 10-Q Filing - Moomoo
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 15 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 47.9 (%) |
| Held by Institutions | 4.5 (%) |
| Shares Short | 173 (K) |
| Shares Short P.Month | 111 (K) |
| EPS | -1.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.22 |
| Profit Margin | -57 % |
| Operating Margin | -10.4 % |
| Return on Assets (ttm) | -62.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -32.8 % |
| Gross Profit (p.s.) | 1.21 |
| Sales Per Share | 1.85 |
| EBITDA (p.s.) | -0.73 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.01 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|